Aseptically Manipulated or Terminally Sterile Medicinal Products

A Tender Notice
by PENINSULA PURCHASING & SUPPLY ALLIANCE

Source
Find a Tender
Type
Contract (Goods)
Duration
4 year
Value
£82M-£80M
Sector
HEALTH
Published
04 May 2023
Delivery
To 15 May 2027 (est.)
Deadline
05 Jun 2023 13:00

Concepts

Location

South West England: Bristol, Devon, Cornwall, Gloucestershire, Somerset & Wiltshire

Geochart for 1 buyers and 0 suppliers

1 buyer

Description

The supply of aseptically manipulated or terminally sterile products to NHS Trusts within the boundaries of the Peninsula Purchasing and Supply Alliance (PPSA). Products include national dose-banded cytotoxic and non-cytotoxic batch and patient specific medicines in ready-to-use infusion bags and pre-filled syringes. This procurement is being managed by the Peninsula Purchasing and Supply Alliance (hereafter referred to as the PPSA) on behalf of the Royal Devon University Healthcare NHS Foundation Trust (hereafter referred to as the Organisation) acting for itself and for Gloucestershire Hospitals NHS Trust, Great Western Hospitals NHS Foundation Trust, Royal Cornwall Hospitals NHS Trust, Salisbury NHS Foundation Trust, Somerset NHS Foundation Trust, Torbay & South Devon NHS Foundation Trust, University Hospitals Plymouth NHS Trust, North Bristol NHS Trust, University Hospitals Bristol & Weston NHS Foundation Trust and the Royal United Hospital Bath NHS Foundation Trust.

Lot Division

1 Aseptically prepared products
  • Value: £46M

Supply of Cyclophosphamide, Doxorubicin & Pembrolizumab compounded ready-to-use batch and patient-specific products. Additional information: The invitation to tender (ITT) documents and additional information is available from CTM e-procurement portal at https://uk.eu-supply.com Tenders or requests to participate must be submitted electronically via the CTM e-procurement portal at https://uk.eu-supply.com If not already registered on CTM eu-supply.com you will need to register as a supplier to express interest.
2 Aseptically prepared products
  • Value: £25M

Supply of Carboplatin, Epirubicin, Nivolumab & Paclitaxel.
3 Aseptically Prepared Products
  • Value: £9M

Supply of Atezolizumab (Tecentriq®), Bortezomib Subcut, Docetaxel, Fluorouracil, Oxaliplatin & Vincristine.
4 Aseptically Prepared Products
  • Value: £2M

Supply of Bleomycin, Cabazitaxel, Calcium folinate, Cisplatin, Cytarabine, Daunorubicin, Ganciclovir, Suxamethonium & Vinblastine.

CPV Codes

  • 33600000 - Pharmaceutical products
  • 33690000 - Various medicinal products
  • 33692100 - Infusion solutions
  • 33692500 - Injectable solutions
  • 33692510 - Intravenous fluids
  • 33693100 - Toxins

Indicators

  • This is a one-off contract (no recurrence)
  • Options are available.
  • Renewals are not available.

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. ** The invitation to tender (ITT) documents and additional information is available from CTM e-procurement portal at: https://uk.eu-supply.com Tenders or requests to participate must be submitted electronically via the above address. This procurement (Lots 1, 2, 3 & 4 - RFT 73313) will be undertaken with Lot 5 framework (RFT 73320) and share the same T22/0446 Invitation to Tender documents (ITT). The following Trusts may join any Contract(s) awarded from the Tender at any time during the Contract Period including Dorset County Hospital NHS Foundation Trust, Jersey General Hospital, Princess Elizabeth Hospital, Guernsey and University Hospitals Dorset NHS Foundation Trust.

Reference

Domains